AVITA Medical, Inc.
US ˙ NasdaqCM ˙ US05380C1027

SecurityRCEL / AVITA Medical, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership157,621 shares
Latest Disclosed Value $ 583,197
Morgan Stanley reports 5.28% increase in ownership of RCEL / AVITA Medical, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 157,621 shares of AVITA Medical, Inc. (US:RCEL) valued at $583,198 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 149,715 shares of AVITA Medical, Inc.. This represents a change in shares of 5.28% during the quarter. The current value of the position is $687,228 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVITA MEDICAL COM 05380C102 157,621 7,906 5.28 583 12.98 0.0000
2026-05-27 2025-12-31 13F/A-1 AVITA MEDICAL COM 05380C102 149,715 52,473 53.96 517 4.03 0.0000
2026-02-13 2025-12-31 13F AVITA MEDICAL COM 05380C102 149,715 52,473 517 0.0000
2026-05-27 2025-09-30 13F/A-1 AVITA MEDICAL COM 05380C102 97,242 -124,951 -56.24 497 -57.79 0.0000
2025-11-14 2025-09-30 13F AVITA MEDICAL COM 05380C102 97,242 -124,951 497 0.0000
2025-08-15 2025-06-30 13F AVITA MEDICAL COM 05380C102 222,193 134,180 152.45 1,175 64.11 0.0001
2025-05-15 2025-03-31 13F AVITA MEDICAL COM 05380C102 88,013 3,097 3.65 716 -34.07 0.0001
2025-05-15 2024-12-31 13F/A-1 AVITA MEDICAL COM 05380C102 84,916 -12,497 -12.83 1,087 4.02 0.0001
2025-02-14 2024-12-31 13F AVITA MEDICAL COM 05380C102 84,916 -12,497 1,087 0.0001
2025-05-14 2024-09-30 13F/A-2 AVITA MEDICAL COM 05380C102 97,413 -11,219 -10.33 1,044 21.40 0.0001
2025-02-14 2024-09-30 13F/A-1 AVITA MEDICAL COM 05380C102 97,413 -11,219 1,044 0.0001
2024-11-14 2024-09-30 13F AVITA MEDICAL COM 05380C102 97,413 -11,219 1,044 0.0000
2025-05-14 2024-06-30 13F/A-2 AVITA MEDICAL COM 05380C102 108,632 68,816 172.84 860 34.80 0.0001
2024-10-17 2024-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 108,632 68,816 860 0.0001
2024-08-14 2024-06-30 13F AVITA MEDICAL COM 05380C102 108,632 68,816 860 0.0001
2024-10-17 2024-03-31 13F/A-2 AVITA MEDICAL COM 05380C102 39,816 -22,482 -36.09 638 -25.29 0.0001
2024-08-16 2024-03-31 13F/A-1 AVITA MEDICAL COM 05380C102 39,816 -22,482 638 0.0000
2024-05-15 2024-03-31 13F AVITA MEDICAL COM 05380C102 39,816 -22,482 638 0.0001
2024-08-16 2023-12-31 13F/A-1 AVITA MEDICAL COM 05380C102 62,298 -96,314 -60.72 855 -63.14 0.0001
2024-02-13 2023-12-31 13F AVITA MEDICAL COM 05380C102 62,298 -96,314 855 0.0001
2023-11-15 2023-09-30 13F AVITA MEDICAL COM 05380C102 158,612 122,565 340.01 2,317 277.98 0.0002
2023-08-14 2023-06-30 13F AVITA MEDICAL COM 05380C102 36,047 -20,674 -36.45 613 -22.60 0.0001
2023-05-15 2023-03-31 13F AVITA MEDICAL COM 05380C102 56,721 38,863 217.62 792 576.92 0.0001
2023-02-14 2022-12-31 13F AVITA MEDICAL COM 05380C102 17,858 -12,591 -41.35 118 -27.33 0.0000
2022-11-14 2022-09-30 13F AVITA MEDICAL COM 05380C102 30,449 -37,077 -54.91 161 -49.69 0.0000
2022-10-27 2022-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 67,526 32,654 93.64 320 8.11 0.0000
2022-08-15 2022-06-30 13F AVITA MEDICAL COM 05380C102 67,526 32,654 320 0.0000
2022-10-27 2022-03-31 13F/A-1 AVITA MEDICAL COM 05380C102 34,872 2,014 6.13 296 -24.68 0.0000
2022-05-13 2022-03-31 13F AVITA MEDICAL COM 05380C102 34,872 2,014 296 0.0000
2022-02-14 2021-12-31 13F AVITA MEDICAL COM 05380C102 32,858 4,282 14.98 393 -22.33 0.0000
2021-11-15 2021-09-30 13F AVITA MEDICAL COM 05380C102 28,576 -9,811 -25.56 506 -35.79 0.0001
2021-08-23 2021-06-30 13F/A-1 AVITA MEDICAL COM 05380C102 38,387 24,407 174.59 788 184.48 0.0001
2021-08-16 2021-06-30 13F AVITA MEDICAL COM 05380C102 38,387 24,407 788 0.0000
2021-05-17 2021-03-31 13F AVITA MEDICAL COM 05380C102 13,980 553 4.12 277 11.24 0.0000
2021-02-16 2020-12-31 13F AVITA THERAPEUTICS COM 05380C102 13,427 -230 -1.68 249 -27.62 0.0000
2020-11-13 2020-09-30 13F AVITA THERAPEUTICS COM 05380C102 13,657 -1,155 -7.80 344 -23.89 0.0001
2020-08-14 2020-06-30 13F AVITA THERAPEUTICS COM 05380C102 14,812 -62,047 -80.73 452 -5.24 0.0001
2020-05-26 2020-03-31 13F/A-1 AVITA MEDICAL SPONSORED ADS 053792107 76,859 -3,939 -4.88 477 -35.10 0.0001
2020-05-15 2020-03-31 13F AVITA MEDICAL SPONSORED ADS 053792107 76,859 -3,939 477 36.6435
2020-02-14 2019-12-31 13F AVITA MED SPONSORED ADS 053792107 80,798 80,798 735 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.